Vertical transmission of HIV is preventable, and we have a duty to ensure the burden of HIV is not handed down across generations.
image source: pexels
The DolPHIN 2 programme investigates the safe and effective use of dolutegravir for women who present with untreated HIV in late pregnancy
The team at the Infectious Diseases Institute, Kampala
DolPHIN 2 is a multinational project led by the University of Liverpool which aims to reduce the rate of vertical transmission of HIV through research into a new HIV drug called dolutegravir.
RT @UNITAID: On #InternationalWomensDay, 8 March, Unitaid remains committed to addressing barriers to improve the lives and health of women in resource-constrained settings.
Discover how Unitaid is bridging the gender divide through access to life-saving innovations: https://t.co/o2mhyMNqbohttps://t.co/HiqKLimxNK
9 months 4 days ago
Laura Else from @LivUniISMIB will be presenting a poster at #CROI2023 today at 14 30 entitled Plasma & urine PK of #dolutegravir and #tenofovir to aid point-of-care testing. Stop by poster 527 to find out more